相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The catalytic mechanism of vitamin K epoxide reduction in a cellular environment
Guomin Shen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Structural basis of antagonizing the vitamin K catalytic cycle for anticoagulation
Shixuan Liu et al.
SCIENCE (2021)
Characterization of Warfarin Inhibition Kinetics Requires Stabilization of Intramembrane Vitamin K Epoxide Reductases
Shuang Li et al.
JOURNAL OF MOLECULAR BIOLOGY (2020)
Competitive tight-binding inhibition of VKORC1 underlies warfarin dosage variation and antidotal efficacy
Shuang Li et al.
BLOOD ADVANCES (2020)
Stabilization of warfarin-binding pocket of VKORC1 and VKORL1 by a peripheral region determines their different sensitivity to warfarin inhibition
G. Shen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Evaluation of oral anticoagulants with vitamin K epoxide reductase in its native milieu
Xuejie Chen et al.
BLOOD (2018)
Membrane Protein Structure in Live Cells: Methodology for Studying Drug Interaction by Mass Spectrometry-Based Footprinting
Guomin Shen et al.
BIOCHEMISTRY (2018)
CHARMM36m: an improved force field for folded and intrinsically disordered proteins
Jing Huang et al.
NATURE METHODS (2017)
Warfarin traps human vitamin K epoxide reductase in an intermediate state during electron transfer
Guomin Shen et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
Warfarin traps human vitamin K epoxide reductase in an intermediate state during electron transfer
Guomin Shen et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
GGCX-Associated Phenotypes: An Overview in Search of Genotype-Phenotype Correlations
Eva Y. G. De Vilder et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Pharmacogenomics Guided-Personalization of Warfarin and Tamoxifen
Theodore J. Wigle et al.
JOURNAL OF PERSONALIZED MEDICINE (2017)
The Arg98Trp mutation in human VKORC1 causing VKCFD2 disrupts a di-arginine-based ER retention motif
Katrin J. Czogalla et al.
BLOOD (2014)
Comparative genetics of warfarin resistance
J. Oldenburg et al.
HAMOSTASEOLOGIE (2014)
Human VKORC1 mutations cause variable degrees of 4-hydroxycoumarin resistance and affect putative warfarin binding interfaces
Katrin J. Czogalla et al.
BLOOD (2013)
Evaluation of warfarin resistance using transcription activator-like effector nucleases-mediated vitamin K epoxide reductase knockout HEK293 cells
J. -K. Tie et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Vitamin K: key vitamin in controlling vascular calcification in chronic kidney disease
Leon J. Schurgers
KIDNEY INTERNATIONAL (2013)
Intracellular glutathione pools are heterogeneously concentrated
Davide Montero et al.
REDOX BIOLOGY (2013)
VKORC1 mutations detected in patients resistant to vitamin K antagonists are not all associated with a resistant VKOR activity
A. Hodroge et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Approaches to Diagnosing and Managing Anticoagulant-Related Bleeding
Jennifer Goy et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2012)
Vitamin K Status and Vascular Calcification: Evidence from Observational and Clinical Studies
M. Kyla Shea et al.
ADVANCES IN NUTRITION (2012)
Novel Insight into the Mechanism of the Vitamin K Oxidoreductase (VKOR) ELECTRON RELAY THROUGH Cys43 AND Cys51 REDUCES VKOR TO ALLOW VITAMIN K REDUCTION AND FACILITATION OF VITAMIN K-DEPENDENT PROTEIN CARBOXYLATION
Mark A. Rishavy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment
M. Watzka et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Pharmacogenomics of 4-hydroxycoumarin anticoagulants
Nicholas Au et al.
DRUG METABOLISM REVIEWS (2008)
Pharmacodynamic resistance to warfarin is associated with nucleotide substitutions in VKORC1
D. J. Harrington et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Multiple genetic alterations in vitamin K epoxide reductase complex subunit 1 gene (VKORC1) can explain the high dose requirement during oral anticoagulation in humans
L. Bodin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Bone health and osteoporosis: The role of vitamin K and potential antagonism by anticoagulants
Debra A. Pearson
NUTRITION IN CLINICAL PRACTICE (2007)
A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistance
Ronen Loebstein et al.
BLOOD (2007)
A new vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with decreased stability of CYP2C9 enzyme
R. L. D'Ambrosio et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Pharmacogenetics of warfarin: current status and future challenges
M. Wadelius et al.
PHARMACOGENOMICS JOURNAL (2007)
Purified vitamin K epoxide reductase alone is sufficient for conversion of vitamin K epoxide to vitamin K and vitamin K to vitamin KH2
Pei-Hsuan Chu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
GROMACS: Fast, flexible, and free
D Van der Spoel et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation
C Geisen et al.
THROMBOSIS AND HAEMOSTASIS (2005)
The genetic basis of resistance to anticoagulants in rodents
HJ Pelz et al.
GENETICS (2005)
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose
MJ Rieder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit I
DJ Harrington et al.
THROMBOSIS AND HAEMOSTASIS (2005)
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
S Rost et al.
NATURE (2004)
Compound heterozygous mutations in the γ-glutamyl carboxylase gene cause combined deficiency of all vitamin K-dependent blood coagulation factors
S Rost et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
分享论文
